Manchester Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.9K Hold
10
﹤0.01% 1051
2026
Q1
$931 Hold
10
﹤0.01% 1148
2025
Q4
$804 Buy
+10
New +$837 ﹤0.01% 1182
2022
Q2
Sell
-65
Closed -$5K 925
2022
Q1
$5K Hold
65
﹤0.01% 633
2021
Q4
$5K Buy
65
+13
+25% +$770 ﹤0.01% 654
2021
Q3
$2K Buy
+52
New +$2.26K ﹤0.01% 835

Other funds holding ACLS

Manchester Capital Management's ACLS Position: Q2 2026 in Review

Manchester Capital Management held its Axcelis (ACLS) position steady in Q2 2026 at 10 shares worth $1.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Manchester Capital Management first reported a position in ACLS in Q3 2021 and has held it in 6 quarters since. The position peaked at $5K in Q1 2022. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Manchester Capital Management held 10 shares of Axcelis worth $1.9K as of Q2 2026.
  • Manchester Capital Management left its Axcelis share count unchanged in Q2 2026.
  • Axcelis made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #1051 holding.
  • Manchester Capital Management first reported a position in Axcelis in Q3 2021 and has held it in 6 quarters since.
  • Manchester Capital Management's Axcelis position peaked at $5K in Q1 2022.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.